메뉴 건너뛰기




Volumn 1, Issue 2, 2008, Pages 105-115

Safety standards: An urgent need for evidence-based regulation

Author keywords

Cost of innovation; Medicine evaluation; Medicines access in developing countries; Public health

Indexed keywords


EID: 79959349593     PISSN: 19933800     EISSN: 19933819     Source Type: Journal    
DOI: 10.5194/sapiens-1-105-2008     Document Type: Article
Times cited : (3)

References (53)
  • 1
    • 0004118752 scopus 로고    scopus 로고
    • Regulating Medicines in Europe: Competition
    • Routledge, London & New York
    • Abraham J. & G. Lewis (2001). Regulating Medicines in Europe: Competition, Expertise and Public Health. Routledge, London & New York.
    • (2001) Expertise and Public Health
    • Abraham, J.1    Lewis, G.2
  • 2
    • 0031741756 scopus 로고    scopus 로고
    • Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine
    • American Academy of Pediatrics
    • American Academy of Pediatrics (1998). Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics, 102, 1483-1491.
    • (1998) Pediatrics , vol.102 , pp. 1483-1491
  • 3
    • 33644977262 scopus 로고    scopus 로고
    • Is technology integration the solution to biotechnology's low research and development productivity?
    • Amir-Aslani A. & S. Negassi (2006). Is technology integration the solution to biotechnology's low research and development productivity? Technovation, 26, 573-582.
    • (2006) Technovation , vol.26 , pp. 573-582
    • Amir-Aslani, A.1    Negassi, S.2
  • 4
    • 14044266006 scopus 로고    scopus 로고
    • Failure Rates in Drug Discovery and Development - Will We Ever Get Any Better?
    • Bains W. (2004). Failure Rates in Drug Discovery and Development - Will We Ever Get Any Better? Drug Discovery World, Vol 5; Part 4, pages 9-19
    • (2004) Drug Discovery World , vol.5 , Issue.4 , pp. 9-19
    • Bains, W.1
  • 5
    • 0142073829 scopus 로고    scopus 로고
    • Cancer patients sue for access to experimental drugs
    • Basu P. (2003). Cancer patients sue for access to experimental drugs. Nature Med vol 9, 10, p1231
    • (2003) Nature Med , vol.9 , Issue.10
    • Basu, P.1
  • 6
    • 19744380776 scopus 로고    scopus 로고
    • Approve trial investigators: Cardiovascular events associated with rofecoxib in a 3-year randomized colorectal adenoma chemoprevention trial
    • Bresalier R. S., Sandler R. S., & H. Quan (2005). Approve trial investigators: Cardiovascular events associated with rofecoxib in a 3-year randomized colorectal adenoma chemoprevention trial. N Engl J Med 352 (11): 1092-1102.
    • (2005) N Engl J Med , vol.352 , Issue.11 , pp. 1092-1102
    • Bresalier R., S.1    Sandler R., S.2    Quan, H.3
  • 7
    • 0032557272 scopus 로고    scopus 로고
    • Measles, Mumps, and Rubella - Vaccine Use and strategies for elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: Recommendations of The Advisory Committee on Immunization Practices (ACIP)
    • Center for Disease Control and Prevention
    • Center for Disease Control and Prevention (1998). "Measles, Mumps, and Rubella - Vaccine Use and strategies for elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: recommendations of The Advisory Committee on Immunization Practices (ACIP) ". MMWR Recomm Rep, 47:1-57.
    • (1998) MMWR Recomm Rep , vol.47 , pp. 1-57
  • 8
    • 0033582884 scopus 로고    scopus 로고
    • Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children-recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention (1999a). Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 48: 1-20.
    • (1999) MMWR Recomm Rep , vol.48 , pp. 1-20
  • 9
    • 0033575158 scopus 로고    scopus 로고
    • Intussusception among recipients of rotavirus vaccine, United States, 1998-1999
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention (1999b). Intussusception among recipients of rotavirus vaccine, United States, 1998-1999. MMWR Morb Mortal Wkly Rep; 48: 577-581.
    • (1999) MMWR Morb Mortal Wkly Rep , vol.48 , pp. 577-581
  • 10
    • 34548519302 scopus 로고    scopus 로고
    • Withdrawal of rotavirus vaccine recommendation
    • Centers for Disease Control and Prevention
    • Centers for Disease Control and Prevention (1999c). Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep; 48: 1007.
    • (1999) MMWR Morb Mortal Wkly Rep , vol.48 , pp. 1007
  • 11
    • 42249091217 scopus 로고    scopus 로고
    • Impugning the integrity of medical science: The adverse effects of industry influence
    • Apr 16
    • DeAngelis C. D. & P. B. Fontanarosa (2008). Impugning the integrity of medical science: the adverse effects of industry influence. JAMA. Apr 16;299(15):1833-1835.
    • (2008) JAMA , vol.299 , Issue.15 , pp. 1833-1835
    • Deangelis, C.D.1    Fontanarosa, P.B.2
  • 12
    • 0037374498 scopus 로고    scopus 로고
    • The price of innovation: New estimates of drug development costs
    • March
    • DiMasi J. A.; Hansen R. W. & Grabowski H. G. (2003). The price of innovation: new estimates of drug development costs. Journal of Health Economics, Volume 22, Number 2, March, pp. 151-185(35).
    • (2003) Journal of Health Economics , vol.22 , Issue.2 , pp. 151-185
    • Dimasi J., A.1    Hansen, R.W.2    Grabowski, H.G.3
  • 13
    • 44949130775 scopus 로고    scopus 로고
    • Fallout from flip-flops
    • Froese P. (2008). Fallout from flip-flops. Nat Biotechnol Jun; 26(6):614-5.
    • (2008) Nat Biotechnol Jun , vol.26 , Issue.6 , pp. 614-615
    • Froese, P.1
  • 14
    • 4444342056 scopus 로고    scopus 로고
    • Rebuilding Big Pharma's Business Model
    • In Vivo, the Business & Medicine Report
    • Gilbert J, P. Henske & A. Singh (2003). "Rebuilding Big Pharma's Business Model," In Vivo, the Business & Medicine Report, Windhover Information, Vol. 21, No. 10.
    • (2003) Windhover Information , vol.21 , Issue.10
    • Gilbert, J.1    Henske, P.2    Singh, A.3
  • 15
    • 2342486044 scopus 로고    scopus 로고
    • The future of rotavirus vaccines: A major setback leads to new opportunities
    • Glass R. I. et al. (2004). The future of rotavirus vaccines: a major setback leads to new opportunities. The Lancet; 363:1547-1550.
    • (2004) The Lancet , vol.363 , pp. 1547-1550
    • Glass, R.I.1
  • 16
    • 79959370577 scopus 로고    scopus 로고
    • A Warning Shot: Influenza and the 2004 Flu Vaccine Shortage
    • Glezen P. (2006). A Warning Shot: Influenza and the 2004 Flu Vaccine Shortage. JAMA; 295: 1316-1317.
    • (2006) JAMA , vol.295 , pp. 1316-1317
    • Glezen, P.1
  • 17
    • 0034870303 scopus 로고    scopus 로고
    • The Precautionary Principle Also Applies to Public Health Actions
    • Goldstein B (2001). The Precautionary Principle Also Applies to Public Health Actions, American Journal of Public Health Vol 91, No. 9, 1358-1361.
    • (2001) American Journal of Public Health , vol.91 , Issue.9 , pp. 1358-1361
    • Goldstein, B.1
  • 19
    • 0031586446 scopus 로고    scopus 로고
    • Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis
    • Joensuu J. et al. (1997). Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet, 350: 1205-1209.
    • (1997) Lancet , vol.350 , pp. 1205-1209
    • Joensuu, J.1
  • 20
    • 34547148986 scopus 로고    scopus 로고
    • Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer
    • Kerr D. J. et al. (2007). Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. N Engl J Med, 357 (4): 360-369.
    • (2007) N Engl J Med , vol.357 , Issue.4 , pp. 360-369
    • Kerr, D.J.1
  • 23
    • 0035067033 scopus 로고    scopus 로고
    • Population-based study of rotavirus vaccination and intussusception
    • Kramarz P., E. K. France & Destefano, F. (2001). Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J; 20: 410-416.
    • (2001) Pediatr Infect Dis J , vol.20 , pp. 410-416
    • Kramarz, P.1    France, E.K.2    Destefano, F.3
  • 24
    • 0034877416 scopus 로고    scopus 로고
    • Reenergizing public health through precaution
    • Kriebel D. & J. Tickner. (2001). Reenergizing public health through precaution. Am J Public Health. 91 (9): 1351-1355.
    • (2001) Am J Public Health , vol.91 , Issue.9 , pp. 1351-1355
    • Kriebel, D.1    Tickner, J.2
  • 25
    • 0036570099 scopus 로고    scopus 로고
    • Timing of new black box warnings and withdrawals for prescription medications
    • Lasser K. E. et al. (2002). Timing of new black box warnings and withdrawals for prescription medications. JAMA. 287:2215-2220.
    • (2002) JAMA , vol.287 , pp. 2215-2220
    • Lasser, K.E.1
  • 26
    • 13844275317 scopus 로고    scopus 로고
    • Strategy for Distribution of Influenza Vaccine to High-Risk Groups and Children
    • Longini I. M. & M. E. Halloran (2005). Strategy for Distribution of Influenza Vaccine to High-Risk Groups and Children. American Journal of Epidemiology 161 (4):303-306.
    • (2005) American Journal of Epidemiology , vol.161 , Issue.4 , pp. 303-306
    • Longini, I.M.1    Halloran, M.E.2
  • 27
    • 34548340711 scopus 로고    scopus 로고
    • The precautionary principle: In action for public health
    • Martuzzi M. (2007). The precautionary principle: in action for public health, Occup Environ Med., 64: 569-570.
    • (2007) Occup Environ Med , vol.64 , pp. 569-570
    • Martuzzi, M.1
  • 28
    • 33845338724 scopus 로고    scopus 로고
    • Projection of global mortality and burden of disease from 2002 to 2030
    • Mathers C. D. & D. Loncar (2006). Projection of global mortality and burden of disease from 2002 to 2030. PLoS Medicine vol 3, 11, 2011-2030.
    • (2006) PLoS Medicine , vol.3 , Issue.11 , pp. 2011-2030
    • Mathers, C.D.1    Loncar, D.2
  • 29
    • 0034702441 scopus 로고    scopus 로고
    • Lifesaving vaccine caught in an ethical minefield
    • Melton L. (2000). Lifesaving vaccine caught in an ethical minefield. The Lancet, 356: 318-319.
    • (2000) The Lancet , vol.356 , pp. 318-319
    • Melton, L.1
  • 30
    • 0033973780 scopus 로고    scopus 로고
    • Policy analysis of the use of hepatitis B and rotavirus vaccines in national immunization schedules
    • Miller M. A. & L. Mc Cann (2000). Policy analysis of the use of hepatitis B and rotavirus vaccines in national immunization schedules. Health Econ, 9, 19-35.
    • (2000) Health Econ , vol.9 , pp. 19-35
    • Miller, M.A.1    McCann, L.2
  • 31
    • 0035931959 scopus 로고    scopus 로고
    • Intussusception among infants given an oral rotavirus vaccine
    • Murphy T. V., P. M. Gargiullo & M. S. Massoudi (2001). Intussusception among infants given an oral rotavirus vaccine. N Engl J Med; 344: 564-572.
    • (2001) N Engl J Med , vol.344 , pp. 564-572
    • Murphy T., V.1    Gargiullo, P.M.2    Massoudi, M.S.3
  • 32
    • 0037446785 scopus 로고    scopus 로고
    • Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions
    • Murphy B. R. et al. (2003). Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J Infect Dis; 187: 1301-1308.
    • (2003) J Infect Dis , vol.187 , pp. 1301-1308
    • Murphy, B.R.1
  • 33
    • 42249100174 scopus 로고    scopus 로고
    • Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: A case study based on documents from rofecoxib litigation
    • Psaty B. M. & R. A. Kronmal (2008). Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation. JAMA;299(15):1813-1817.
    • (2008) JAMA , vol.299 , Issue.15 , pp. 1813-1817
    • Psaty, B.M.1    Kronmal, R.A.2
  • 34
    • 42249098105 scopus 로고    scopus 로고
    • Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents From Rofecoxib Litigation
    • Ross JS. et al. (2008). Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents From Rofecoxib Litigation. JAMA vol. 299, no 15, 1800-1812.
    • (2008) JAMA , vol.299 , Issue.15 , pp. 1800-1812
    • Ross, J.S.1
  • 35
    • 0030027092 scopus 로고    scopus 로고
    • Evidence-Based medicine: What it is and what it isn't
    • Sackett D. L. et al. (1996). Evidence-Based medicine: what it is and what it isn't, BMJ; 312:71-72.
    • (1996) BMJ , vol.312 , pp. 71-72
    • Sackett, D.L.1
  • 36
    • 0035856244 scopus 로고    scopus 로고
    • Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception
    • Simonsen L. et al. (2001). Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. The Lancet, vol 358, 1224-1229.
    • (2001) The Lancet , vol.358 , pp. 1224-1229
    • Simonsen, L.1
  • 37
    • 33646183685 scopus 로고    scopus 로고
    • How the US drug safety system should be changed
    • Strom B. (2006). How the US drug safety system should be changed, JAMA 295:2072-2075.
    • (2006) JAMA , vol.295 , pp. 2072-2075
    • Strom, B.1
  • 38
    • 0037425564 scopus 로고    scopus 로고
    • Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
    • Thompson W. W et al. (2003). Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States: JAMA.: 289:179-186.
    • (2003) JAMA , vol.289 , pp. 179-186
    • Thompson, W.W.1
  • 39
    • 0032490140 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of a rotavirus immunization program for the United States
    • Tucker A. W. et al. (1998). Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA, 279: 1371-1376.
    • (1998) JAMA , vol.279 , pp. 1371-1376
    • Tucker, A.W.1
  • 40
    • 30044442208 scopus 로고    scopus 로고
    • Safety and efficacy of a pentavalent Human - Bovine (WC3) reassortant rotavirus vaccine
    • Vesikari T., D. O. Matson & P. Dennehy (2006). Safety and efficacy of a pentavalent Human - Bovine (WC3) reassortant rotavirus vaccine. N Engl J Med; 354 (1): 75-77.
    • (2006) N Engl J Med , vol.354 , Issue.1 , pp. 75-77
    • Vesikari, T.1    Matson, D.O.2    Dennehy, P.3
  • 41
    • 37549024247 scopus 로고    scopus 로고
    • Regulator under siege
    • Dec 20
    • Wadman M. (2007). Regulator under siege. Nature. Dec 20;450(7173):1143
    • (2007) Nature , vol.450 , Issue.7173 , pp. 1143
    • Wadman, M.1
  • 42
    • 0038445612 scopus 로고    scopus 로고
    • Applying an equity lens to child health and mortality: More of the same is not enough
    • Victora C. G. et al. (2003). Applying an equity lens to child health and mortality: more of the same is not enough. The Lancet: vol 362: 233-241.
    • (2003) The Lancet , vol.362 , pp. 233-241
    • Victora, C.G.1
  • 43
    • 0034596547 scopus 로고    scopus 로고
    • The future of research into rotavirus vaccine. Benefits of vaccines may outweigh risk for children in developing country
    • Wejner C. (2000). The future of research into rotavirus vaccine. Benefits of vaccines may outweigh risk for children in developing country. BMJ, 321, 525-526.
    • (2000) BMJ , vol.321 , pp. 525-526
    • Wejner, C.1
  • 45
    • 10944252009 scopus 로고    scopus 로고
    • Ethics Versus Evidence In Influenza Vaccination
    • Zambon M. (2004). Ethics versus evidence in influenza vaccination. The Lancet, Vol 364, 9452: 2161-2163.
    • (2004) The Lancet , vol.364 , Issue.9452 , pp. 2161-2163
    • Zambon, M.1
  • 46
    • 79959347576 scopus 로고    scopus 로고
    • WEB SITES About EMEA structure, Accessed 1st July 2008, Permanent link
    • WEB SITES About EMEA structure: http://www.emea.europa.eu/htms/aboutus/emeaoverview.htm. Accessed 1st July 2008. Permanent link: http://www.webcitation.org/5Yz8KZstJ
  • 47
    • 79959342840 scopus 로고    scopus 로고
    • Sequence of Events with VIOXX, since opening of IND, Accessed 1st July 2008, Permanent link
    • Sequence of Events with VIOXX, since opening of IND: http://www.fda.gov/OHRMS/DOCKETS/AC/05/briefing/2005-4090B1_04_EFDA-TAB-C.htm Accessed 1st July 2008. Permanent link: http://www.webcitation.org/5Yz8VV9LG
  • 48
    • 79959362285 scopus 로고    scopus 로고
    • Jesse L. Goodman, M. D., M. P. H. Director, Center for Biologics, Evaluation and Research, May 4, 2005, Before the Committee on Energy and Commerce United States House of Representatives, Accessed 1st July 2008, Permanent link
    • Statement on influenza vaccine supply needs, Jesse L. Goodman, M. D., M. P. H. Director, Center for Biologics, Evaluation and Research, May 4, 2005, Before the Committee on Energy and Commerce United States House of Representatives. http://www.fda.gov/bbs/topics/news/2005/NEW01160.html, and: Accessed 1st July 2008. Permanent link: http://www.webcitation.org/5Yz7nqXMICDC
    • Statement On Influenza Vaccine Supply Needs
  • 49
    • 79959358630 scopus 로고    scopus 로고
    • Testimony February 10, 2005 on US Influenza Supply and Preparations for the Future before The Committee on Government Reform United States House of Representatives, Accessed 1st July 2008. Permanent link
    • Testimony February 10, 2005 on US Influenza Supply and Preparations for the Future before The Committee on Government Reform United States House of Representatives. http://www.hhs.gov/asl/testify/t050210b.html, Accessed 1st July 2008. Permanent link: http://www.webcitation.org/5Yz4uC1QxWHO
  • 50
    • 79959370099 scopus 로고    scopus 로고
    • World Health Report 2007, Permanent link, Accessed 1st July 2008
    • World Health Report 2007: http://www.who.int/whr/2007/chapter1/en/index.html, and: Permanent link http://www.webcitation.org/5Yz4NP83K Accessed 1st July 2008.
  • 52
    • 79959372061 scopus 로고    scopus 로고
    • US Department of Health and Human Services, Accessed 1st July 2008
    • US Department of Health and Human Services: http://www.hhs.gov/news/press/2006pres/20060504.html Accessed 1st July 2008. http://www.webcitation.org/5Yz3dSerh
  • 53
    • 79959340235 scopus 로고    scopus 로고
    • Sanofi-Aventis press releases, Accessed 1st July 2008, Permanent link
    • Sanofi-Aventis press releases: http://en.sanofi-aventis.com/press/ppc_18636.asp Accessed 1st July 2008. Permanent link: http://www.webcitation.org/5Yz3ar23n


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.